These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

565 related articles for article (PubMed ID: 33857425)

  • 21. Single-Cell RNA-Sequencing Shift in the Interaction Pattern Between Glioma Stem Cells and Immune Cells During Tumorigenesis.
    Zhai Y; Li G; Li R; Chang Y; Feng Y; Wang D; Wu F; Zhang W
    Front Immunol; 2020; 11():581209. PubMed ID: 33133100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bmi1 regulates human glioblastoma stem cells through activation of differential gene networks in CD133+ brain tumor initiating cells.
    Vora P; Seyfrid M; Venugopal C; Qazi MA; Salim S; Isserlin R; Subapanditha M; O'Farrell E; Mahendram S; Singh M; Bakhshinyan D; Chokshi C; McFarlane N; Dvorkin-Gheva A; Brown KR; Murty N; Moffat J; Bader GD; Singh SK
    J Neurooncol; 2019 Jul; 143(3):417-428. PubMed ID: 31115870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective lentiviral gene delivery to CD133-expressing human glioblastoma stem cells.
    Bayin NS; Modrek AS; Dietrich A; Lebowitz J; Abel T; Song HR; Schober M; Zagzag D; Buchholz CJ; Chao MV; Placantonakis DG
    PLoS One; 2014; 9(12):e116114. PubMed ID: 25541984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
    Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W
    J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MLL5 Orchestrates a Cancer Self-Renewal State by Repressing the Histone Variant H3.3 and Globally Reorganizing Chromatin.
    Gallo M; Coutinho FJ; Vanner RJ; Gayden T; Mack SC; Murison A; Remke M; Li R; Takayama N; Desai K; Lee L; Lan X; Park NI; Barsyte-Lovejoy D; Smil D; Sturm D; Kushida MM; Head R; Cusimano MD; Bernstein M; Clarke ID; Dick JE; Pfister SM; Rich JN; Arrowsmith CH; Taylor MD; Jabado N; Bazett-Jones DP; Lupien M; Dirks PB
    Cancer Cell; 2015 Dec; 28(6):715-729. PubMed ID: 26626085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glioblastoma Exhibits Inter-Individual Heterogeneity of TSPO and LAT1 Expression in Neoplastic and Parenchymal Cells.
    Cai L; Kirchleitner SV; Zhao D; Li M; Tonn JC; Glass R; Kälin RE
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic modulation of metabolism in glioblastoma.
    Dong Z; Cui H
    Semin Cancer Biol; 2019 Aug; 57():45-51. PubMed ID: 30205139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Preclinical Investigation of GBM-N019 as a Potential Inhibitor of Glioblastoma via Exosomal mTOR/CDK6/STAT3 Signaling.
    Wu ATH; Huang HS; Wen YT; Lawal B; Mokgautsi N; Huynh TT; Hsiao M; Wei L
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
    Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
    J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extracellular adenosine promotes cell migration/invasion of Glioblastoma Stem-like Cells through A
    Torres Á; Erices JI; Sanchez F; Ehrenfeld P; Turchi L; Virolle T; Uribe D; Niechi I; Spichiger C; Rocha JD; Ramirez M; Salazar-Onfray F; San Martín R; Quezada C
    Cancer Lett; 2019 Apr; 446():112-122. PubMed ID: 30660649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. YAP/TAZ Transcriptional Coactivators Create Therapeutic Vulnerability to Verteporfin in EGFR-mutant Glioblastoma.
    Vigneswaran K; Boyd NH; Oh SY; Lallani S; Boucher A; Neill SG; Olson JJ; Read RD
    Clin Cancer Res; 2021 Mar; 27(5):1553-1569. PubMed ID: 33172899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR128-1 inhibits the growth of glioblastoma multiforme and glioma stem-like cells via targeting BMI1 and E2F3.
    Shan ZN; Tian R; Zhang M; Gui ZH; Wu J; Ding M; Zhou XF; He J
    Oncotarget; 2016 Nov; 7(48):78813-78826. PubMed ID: 27705931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ALKBH5 Facilitates Hypoxia-Induced Paraspeckle Assembly and IL8 Secretion to Generate an Immunosuppressive Tumor Microenvironment.
    Dong F; Qin X; Wang B; Li Q; Hu J; Cheng X; Guo D; Cheng F; Fang C; Tan Y; Yan H; He Y; Sun X; Yuan Y; Liu H; Li T; Zhao Y; Kang C; Wu X
    Cancer Res; 2021 Dec; 81(23):5876-5888. PubMed ID: 34670781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune microenvironment of experimental rat C6 gliomas resembles human glioblastomas.
    Gieryng A; Pszczolkowska D; Bocian K; Dabrowski M; Rajan WD; Kloss M; Mieczkowski J; Kaminska B
    Sci Rep; 2017 Dec; 7(1):17556. PubMed ID: 29242629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exploring the prognostic value of BRMS1 + microglia based on single-cell anoikis regulator patterns in the immunologic microenvironment of GBM.
    Zhao S; Ni K; Xie J; Cheng C; Zhao N; Liu J; Ji W; Wang Q; Zhang P; Liu Y
    J Neurooncol; 2024 Oct; 170(1):101-117. PubMed ID: 39143438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glioblastoma stem cell metabolism and immunity.
    Hawly J; Murcar MG; Schcolnik-Cabrera A; Issa ME
    Cancer Metastasis Rev; 2024 Sep; 43(3):1015-1035. PubMed ID: 38530545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TLR4 expression and functionality are downregulated in glioblastoma cells and in tumor-associated macrophages: A new mechanism of immune evasion?
    da Cruz LLP; de Souza PO; Dal Prá M; Falchetti M; de Abreu AM; Azambuja JH; Bertoni APS; Paz AHR; Araújo AB; Visioli F; Fazolo T; da Silva GG; Worm PV; Wink MR; Zanotto-Filho A; Braganhol E
    Biochim Biophys Acta Mol Basis Dis; 2021 Aug; 1867(8):166155. PubMed ID: 33932524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Dynamics of Interactions Among Immune and Glioblastoma Cells.
    Eder K; Kalman B
    Neuromolecular Med; 2015 Dec; 17(4):335-52. PubMed ID: 26224516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. On-target JAK2/STAT3 inhibition slows disease progression in orthotopic xenografts of human glioblastoma brain tumor stem cells.
    Stechishin OD; Luchman HA; Ruan Y; Blough MD; Nguyen SA; Kelly JJ; Cairncross JG; Weiss S
    Neuro Oncol; 2013 Feb; 15(2):198-207. PubMed ID: 23262510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progression from low- to high-grade in a glioblastoma model reveals the pivotal role of immunoediting.
    Appolloni I; Alessandrini F; Ceresa D; Marubbi D; Gambini E; Reverberi D; Loiacono F; Malatesta P
    Cancer Lett; 2019 Feb; 442():213-221. PubMed ID: 30312732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.